Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 removed. This appears to be an administrative version update that does not alter study details or navigation on the page.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded a 'Show glossary' option and minor metadata/label updates (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision note updated: Revision v3.3.4 has been added and Revision v3.3.3 has been removed.SummaryDifference0.0%

- Check45 days agoChange DetectedA consolidated Locations section lists all site locations by state and the revision shows v3.3.3. Individual state location subsections (e.g., California Locations, Colorado Locations) were removed.SummaryDifference2%

- Check66 days agoChange DetectedThe page footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows a site revision update from v3.2.0 to v3.3.1, with no changes to the study content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.